Ironwood Pharmaceuticals | IRWD - Interest Income


Ironwood Pharmaceuticals reported $778K in Interest Income for its fiscal quarter ending in December of 2024.





Interest Income Change Date
Acadia Pharmaceuticals USD 8.25M 1M Sep/2025
Agios Pharmaceuticals USD 13.37M 1.14M Sep/2025
Almirall EUR 2.71M 580K Dec/2025
Alnylam Pharmaceuticals USD 28.68M 1.19M Sep/2025
Amarin USD 3.37M 3.37M Dec/2024
Astellas Pharma JPY 4.12B 2.94B Mar/2024
AstraZeneca USD 85M 17M Sep/2025
Charles River Laboratories USD 1.1 1.1M Sep/2025
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Incyte USD 30.75M 3.97M Dec/2025
Ironwood Pharmaceuticals USD 778K 374K Dec/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
MacroGenics USD 1.53M 114K Sep/2025
Moderna USD 73M 8M Sep/2025
Myriad Genetics USD 300K 0 Mar/2025
Pacira USD 8.53M 3.53M Sep/2025
Puma Biotechnology USD 0.41 0.5 Sep/2024
Sarepta Therapeutics USD 8.38M 1.24M Sep/2025
Takeda JPY 87.87B 43.48B Dec/2025
Ultragenyx Pharmaceutical USD 5.86M 69K Sep/2025